These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15292905)

  • 1. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
    Diergaarde L; de Vries W; Raasø H; Schoffelmeer AN; De Vries TJ
    Neuropharmacology; 2008 Oct; 55(5):712-6. PubMed ID: 18588903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
    Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
    Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.
    Le Foll B; Goldberg SR
    Neuroreport; 2004 Sep; 15(13):2139-43. PubMed ID: 15486497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats.
    Shoaib M
    Neuropharmacology; 2008 Feb; 54(2):438-44. PubMed ID: 18054052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats.
    Forget B; Hamon M; Thiébot MH
    Psychopharmacology (Berl); 2005 Oct; 181(4):722-34. PubMed ID: 15986197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
    de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
    Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinstatement of nicotine-seeking behavior by drug-associated stimuli after extinction in rats.
    Liu X; Caggiula AR; Yee SK; Nobuta H; Poland RE; Pechnick RN
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):417-25. PubMed ID: 16163522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Ward SJ; Rosenberg M; Dykstra LA; Walker EA
    Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats.
    Fang Q; Li FQ; Li YQ; Xue YX; He YY; Liu JF; Lu L; Wang JS
    Pharmacol Biochem Behav; 2011 Oct; 99(4):738-42. PubMed ID: 21722663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
    Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA
    Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
    Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
    Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
    Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortico-limbic circuitry for conditioned nicotine-seeking behavior in rats involves endocannabinoid signaling.
    Kodas E; Cohen C; Louis C; Griebel G
    Psychopharmacology (Berl); 2007 Oct; 194(2):161-71. PubMed ID: 17557151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
    Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
    Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A.
    De Vries TJ; de Vries W; Janssen MC; Schoffelmeer AN
    Behav Brain Res; 2005 Jun; 161(1):164-8. PubMed ID: 15904723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
    Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
    Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats.
    Cohen C; Perrault G; Voltz C; Steinberg R; Soubrié P
    Behav Pharmacol; 2002 Sep; 13(5-6):451-63. PubMed ID: 12394421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.
    Liu X; Palmatier MI; Caggiula AR; Sved AF; Donny EC; Gharib M; Booth S
    Psychopharmacology (Berl); 2009 Mar; 202(4):589-98. PubMed ID: 18807246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.